LI_183755
|
Pages: NA
|
Mar 2019 | 828 Views
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*: |
|
Wearable injectors are drug delivery devices based on single-use wearable device technologies, designed to deliver drugs in large volume to the patients treated for long duration. Rapid ongoing developments with many new designed features of these have been witnessed in the medical field. Wearable injectors offer numerous benefits to the patients due to their wide usage.
The global wearable injectors market is driven by the advantages as compared to traditional injectors, ease of customization, and increase in demand for home healthcare and advanced drug delivery system. Growth in need for subcutaneous and continuous drug delivery has created the demand for wearable injectors among the patients. However, low dosing volume of administering drugs and highly viscous nature of few drugs impede the market growth. Moreover, rise in need for better patient care and growth in focus of pharmaceutical companies to penetrate in the market offer ample opportunities for market development.
The global wearable injectors market is segmented based on type, usage, technology, mechanism of injection, therapeutic area, end user, and region. On the basis of type, it is divided into on-body {adhesive patch}, off-body {belt clip}, and hand-held. Based on usage, it is bifurcated into disposable and semi-reusable. Based on technology, it is classified into electronic injectors, mechanical injectors, and others. On the basis of mechanism of injection, it is categorized into motor-driven, spring-based, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. On the basis of therapeutic area, it is divided into diabetes, oncology, cardiovascular diseases, infectious diseases, and auto-immune disorders. Based on end user, it is divided into clinics, hospitals, ambulatory surgery centers, home care settings, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market are Enable Injections, SteadyMed Therapeutics, Inc., Insulet Corporation, UNILIFE CORPORATION, Sensile Medical AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Bhler Motor GmbH, Ypsomed, and Amgen Inc.,
Key Benefits
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.